News
EUROAPI, a European leader in the production of active pharmaceutical ingredients (API) and contract development and ...
The move will enable the company to strengthen its foothold in the US and establish its presence in the fast-growing global ...
The Trump administration is eroding national pandemic flu defenses as it guts health agencies, cuts research and health ...
Trends in certain forms of drug delivery, as well as the emergence of artificial intelligence, are playing roles in evolving ...
Biodextris, a leading Contract Development and Manufacturing Organization (CDMO) rooted in the legacy of GSK's biologics and vaccine operations and backed by the healthcare-focused private equity firm ...
Trump also has signaled he wants to gut the federal CDFI Fund, which serves disadvantaged businesses. Oregon’s Manufacturing ...
After a long winter, the start of summer is ushering in some much-needed sunshine, warmer weather and, for a handful of ...
The nutraceutical CDMO market is anticipated to expand at a CAGR of ~8% during the forecast period. Key drivers of this ...
Cellares, a pioneer in automated cell therapy manufacturing, is establishing a next-gen commercial production site for CAR-T ...
Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization, ...
Cellares will open Japan’s first automated CAR-T cell therapy factory in Kashiwa City, boosting global production.
Piramal Pharma announced that the United States Food and Drug Administration (USFDA) has completed a general good manufacturing practices (GMP) inspection at its manufacturing facility in Aurora, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results